Evidence map›Paper›PMID 38649831›Full record

ReviewBMC nephrology2024

A loss-of-function AGTR1 variant in a critically-ill infant with renal tubular dysgenesis: case presentation and literature review.

Aljazi Al-Maraghi, Waleed Aamer, Mubarak Ziab, Elbay Aliyev, Najwa Elbashir, Sura Hussein, Sasirekha Palaniswamy, Dhullipala Anand, Donald R Love, Adrian Charles and 2 more

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in BMC nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Aljazi Al-MaraghiLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Waleed AamerLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Mubarak ZiabDepartment of Human Genetics-Precision Medicine in Diabetes Prevention, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Elbay AliyevLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Najwa ElbashirLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Sura HusseinLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Sasirekha PalaniswamyLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Dhullipala AnandNeonatology Division, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Donald R LoveGenetic Pathology, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Adrian CharlesAnatomical Pathology, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Ammira A S AkilDepartment of Human Genetics-Precision Medicine in Diabetes Prevention, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Khalid A FakhroLaboratory of Genomic Medicine, Sidra Medicine, P.O. Box 26999, Doha, Qatar. kfakhro@sidra.org.
Qatar Airways (Qatar) · QAHamad bin Khalifa University · QA

Funding

Qatar National Research Fund NPRP11S-0110-180250
6 · The paper itself

Abstract

backgroundRenal tubular dysgenesis (RTD) is a severe disorder with poor prognosis significantly impacting the proximal tubules of the kidney while maintaining an anatomically normal gross structure. The genetic origin of RTD, involving variants in the ACE, REN, AGT, and AGTR1 genes, affects various enzymes or receptors within the Renin angiotensin system (RAS). This condition manifests prenatally with oligohydramninos and postnatally with persistent anuria, severe refractory hypotension, and defects in skull ossification. CASE PRESENTATION: In this report, we describe a case of a female patient who, despite receiving multi vasopressor treatment, experienced persistent hypotension, ultimately resulting in early death at five days of age. While there was a history of parental consanguinity, no reported family history of renal disease existed. Blood samples from the parents and the remaining DNA sample of the patient underwent Whole Genome Sequencing (WGS). The genetic analysis revealed a rare homozygous loss of function variant (NM_000685.5; c.415C > T; p.Arg139*) in the Angiotensin II Receptor Type 1 (AGTR1) gene.

conclusionThis case highlights the consequence of loss-of-function variants in AGTR1 gene leading to RTD, which is characterized by high mortality rate at birth or during the neonatal period. Furthermore, we provide a comprehensive review of previously reported variants in the AGTR1 gene, which is the least encountered genetic cause of RTD, along with their associated clinical features.

Indexed as

Receptor, Angiotensin, Type 1Urogenital AbnormalitiesFatal OutcomeFemaleHumansHypotensionInfant, NewbornKidney Tubules, ProximalLoss of Function MutationAGTR1 protein, humanReceptor, Angiotensin, Type 1AGTR1Middle EastRare Mendelian diseaseRenal tubular dysgenesisWhole genome sequencing

Identifiers

PMID38649831
PMCPMC11034062
OpenAlexW4395002353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.